Effect of Empagliflozin on the Metabolic Signature of Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease

被引：145
作者：
Kappel, Ben A. [1 ]
Lehrke, Michael [1 ]
Schutt, Katharina [1 ]
Artati, Anna [2 ]
Adamski, Jerzy [2 ,3 ,4 ]
Lebherz, Corinna [1 ]
Marx, Nikolaus [1 ]
机构：
[1] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Internal Med 1, Pauwelsstr 30, D-52074 Aachen, Germany
[2] German Res Ctr Environm Hlth, Helmholtz Zentrum Muchen, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany
[3] Tech Univ Munich, Life & Food Sci Ctr Weihenstephan, Inst Expt Genet, Freising Weihenstephan, Germany
[4] German Ctr Diabet Res, Neuherberg, Germany
来源：
CIRCULATION | 2017年 / 136卷 / 10期
关键词：
branched-chain amino acids; cardiovascular disease; empagliflozin; ketone bodies; metabolomics; SGTL2; inhibitors; type 2 diabetes mellitus; OUTCOMES;
D O I：
10.1161/CIRCULATIONAHA.117.029166
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：969 / 972
页数：4
相关论文
共 50 条
[11]   Implementation of Empagliflozin in Patients with Diabetes Mellitus Type 2 and Established Cardiovascular Disease: Estimation of 5-Year Survival and Costs in Sweden [J].
Bernfort, Lars ;
Husberg, Magnus ;
Wirehn, Ann-Britt ;
Rosenqvist, Ulf ;
Gustavsson, Staffan ;
Karlsdotter, Kristina ;
Levin, Lars-Ake .
DIABETES THERAPY, 2020, 11 (12) :2921-2930
[12]   Predictors of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus [J].
Tan, M. C. ;
Wong, T. W. ;
Chan, Y. M. ;
Joseph, A. ;
Hejar, A. R. ;
Ng, O. C. .
INTERNATIONAL JOURNAL OF COLLABORATIVE RESEARCH ON INTERNAL MEDICINE & PUBLIC HEALTH, 2013, 5 (07) :492-506
[13]   Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus [J].
Fujihara, Kazuya ;
Sone, Hirohito .
ANNALS OF VASCULAR DISEASES, 2018, 11 (01) :2-14
[14]   Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK [J].
Lautsch, Dominik ;
Wang, Tongtong ;
Yang, Lingfeng ;
Rajpathak, Swapnil N. .
DIABETES THERAPY, 2019, 10 (06) :2131-2137
[15]   Empagliflozin/linagliptin single-pill combination therapy for patients with type 2 diabetes mellitus [J].
Jain, Rajeev Kumar .
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (06) :545-549
[16]   Type 2 diabetes mellitus and cardiovascular disease: focus on the effect of antihyperglycemic treatments on cardiovascular outcomes [J].
Choxi, Ravi ;
Roy, Sumon ;
Stamatouli, Angeliki ;
Mayer, Stephanie B. ;
Jovin, Ion S. .
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (04) :187-199
[17]   Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus [J].
Kim, Jee-Heon ;
Yoon, Young-Chae ;
Kim, Young-Hoon ;
Park, Jong-Il ;
Choi, Kang-Un ;
Nam, Jong-Ho ;
Lee, Chan-Hee ;
Son, Jang-Won ;
Park, Jong-Seon ;
Kim, Ung .
CLINICAL CARDIOLOGY, 2024, 47 (03)
[18]   Metabolic and renal outcomes of empagliflozin in patients with type 2 diabetes mellitus attending Armed Forces Hospital in Saudi Arabia [J].
Alshahrani, Ali A. ;
Al Qahtani, Saad S. ;
Al Qahtani, Abrar S. ;
Mashhour, Saeed M. ;
Alkhtani, Zayed S. ;
Alragea, Yahya M. .
SAUDI MEDICAL JOURNAL, 2023, 44 (07) :674-678
[19]   Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study [J].
Patoulias, Dimitrios ;
Papadopoulos, Christodoulos ;
Zografou, Ioanna ;
Katsimardou, Alexandra ;
Karagiannis, Asterios ;
Doumas, Michael .
MEDICINA-LITHUANIA, 2022, 58 (09)
[20]   Usefulness of Empagliflozin Versus Oral Semaglutide for Prevention of Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus [J].
Hammerman, Ariel ;
Moore, Candace Makeda ;
Aboalhasan, Enis ;
Azuri, Joseph ;
Arbel, Ronen .
AMERICAN JOURNAL OF CARDIOLOGY, 2022, 170 :128-131
12345